Drug developer BenevolentAI faces founder-led board revolt
BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.
Stay updated with breaking news from Baroness Shields. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.
Baroness Shields has stepped down as chief executive of BenevolentAI as the drugs developer pushes ahead with a widespread restructuring.Shields, 61, a former t
The biotechnology company led by Baroness Shields, the former technology adviser to David Cameron, is to cut about half of its workforce as it redraws it
Financial institutions and developers around the world are on alert last night after Evergrande warned it will not be able to pay back its debts.
Benevolent AI, which is run by Joanna Shields (pictured) uses artificial intelligence (AI) to speed up the development of drugs.